859 related articles for article (PubMed ID: 25536258)
1. Metformin in patients with type 2 diabetes and kidney disease: a systematic review.
Inzucchi SE; Lipska KJ; Mayo H; Bailey CJ; McGuire DK
JAMA; 2014 Dec 24-31; 312(24):2668-75. PubMed ID: 25536258
[TBL] [Abstract][Full Text] [Related]
2. Association of Metformin Use With Risk of Lactic Acidosis Across the Range of Kidney Function: A Community-Based Cohort Study.
Lazarus B; Wu A; Shin JI; Sang Y; Alexander GC; Secora A; Inker LA; Coresh J; Chang AR; Grams ME
JAMA Intern Med; 2018 Jul; 178(7):903-910. PubMed ID: 29868840
[TBL] [Abstract][Full Text] [Related]
3. Metformin: time to review its role and safety in chronic kidney disease.
Tanner C; Wang G; Liu N; Andrikopoulos S; Zajac JD; Ekinci EI
Med J Aust; 2019 Jul; 211(1):37-42. PubMed ID: 31187887
[TBL] [Abstract][Full Text] [Related]
4. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Salpeter S; Greyber E; Pasternak G; Salpeter E
Cochrane Database Syst Rev; 2003; (2):CD002967. PubMed ID: 12804446
[TBL] [Abstract][Full Text] [Related]
5. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Salpeter S; Greyber E; Pasternak G; Salpeter E
Cochrane Database Syst Rev; 2002; (2):CD002967. PubMed ID: 12076461
[TBL] [Abstract][Full Text] [Related]
6. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Salpeter S; Greyber E; Pasternak G; Salpeter E
Cochrane Database Syst Rev; 2006 Jan; (1):CD002967. PubMed ID: 16437448
[TBL] [Abstract][Full Text] [Related]
7. Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? No, We Should Never Again Compromise Safety!
Kalantar-Zadeh K; Kovesdy CP
Diabetes Care; 2016 Jul; 39(7):1281-6. PubMed ID: 27330129
[TBL] [Abstract][Full Text] [Related]
8. Metformin in chronic kidney disease: time for a rethink.
Heaf J
Perit Dial Int; 2014 Jun; 34(4):353-7. PubMed ID: 24711640
[TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis of lactic acidosis-related parameters upon and after metformin discontinuation in patients with diabetes and chronic kidney disease.
Sipahi S; Solak Y; Acikgoz SB; Genc AB; Yildirim M; Yilmaz U; Nalbant A; Tamer A
Int Urol Nephrol; 2016 Aug; 48(8):1305-1312. PubMed ID: 27102431
[TBL] [Abstract][Full Text] [Related]
10. Should Restrictions Be Relaxed for Metformin Use in Chronic Kidney Disease? Yes, They Should Be Relaxed! What's the Fuss?
Bakris GL; Molitch ME
Diabetes Care; 2016 Jul; 39(7):1287-91. PubMed ID: 27330130
[TBL] [Abstract][Full Text] [Related]
11. Unleash metformin: reconsideration of the contraindication in patients with renal impairment.
Lu WR; Defilippi J; Braun A
Ann Pharmacother; 2013 Nov; 47(11):1488-97. PubMed ID: 24259604
[TBL] [Abstract][Full Text] [Related]
12. Hospitalization for Lactic Acidosis Among Patients With Reduced Kidney Function Treated With Metformin or Sulfonylureas.
Chu PY; Hackstadt AJ; Chipman J; Griffin MR; Hung AM; Greevy RA; Grijalva CG; Elasy T; Roumie CL
Diabetes Care; 2020 Jul; 43(7):1462-1470. PubMed ID: 32327421
[TBL] [Abstract][Full Text] [Related]
13. Risks of Metformin in Type 2 Diabetes and Chronic Kidney Disease: Lessons Learned from Taiwanese Data.
Rhee CM; Kovesdy CP; Kalantar-Zadeh K
Nephron; 2017; 135(2):147-153. PubMed ID: 27760420
[TBL] [Abstract][Full Text] [Related]
14. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Salpeter SR; Greyber E; Pasternak GA; Salpeter EE
Cochrane Database Syst Rev; 2010 Apr; 2010(4):CD002967. PubMed ID: 20393934
[TBL] [Abstract][Full Text] [Related]
15. Lactic acidosis associated with metformin in patients with moderate to severe chronic kidney disease: study protocol for a multicenter population-based case-control study using health databases.
Pedrós C; Ávila M; Gómez-Lumbreras A; Manríquez M; Morros R;
BMC Nephrol; 2019 May; 20(1):193. PubMed ID: 31146690
[TBL] [Abstract][Full Text] [Related]
16. [Proposal for the modification of metformin use in patients with chronic kidney disease].
Balogh Z; Mátyus J
Orv Hetil; 2012 Sep; 153(39):1527-35. PubMed ID: 23000419
[TBL] [Abstract][Full Text] [Related]
17. Metformin in patients with chronic kidney disease: strengths and weaknesses.
Rocha A; Almeida M; Santos J; Carvalho A
J Nephrol; 2013; 26(1):55-60. PubMed ID: 22641582
[TBL] [Abstract][Full Text] [Related]
18. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Salpeter SR; Greyber E; Pasternak GA; Salpeter Posthumous EE
Cochrane Database Syst Rev; 2010 Jan; (1):CD002967. PubMed ID: 20091535
[TBL] [Abstract][Full Text] [Related]
19. The Association between Metformin Therapy and Lactic Acidosis.
Kuan IHS; Savage RL; Duffull SB; Walker RJ; Wright DFB
Drug Saf; 2019 Dec; 42(12):1449-1469. PubMed ID: 31372935
[TBL] [Abstract][Full Text] [Related]
20. Lactic acidosis induced by metformin: incidence, management and prevention.
Lalau JD
Drug Saf; 2010 Sep; 33(9):727-40. PubMed ID: 20701406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]